অনুসন্ধান ফলাফলগুলি - Miso Kim
- প্রদর্শন 1 - 20 ফলাফল এর 22
- পরবর্তী পৃষ্ঠায় যান
-
1
The Korea National Disability Registration System অনুযায়ী Miso Kim, Wonyoung Jung, So Young Kim, Jong Hyock Park, Dong Wook Shin
প্রকাশিত 2023Artigo -
2
-
3
Laminar Flow Activation of ERK5 Protein in Vascular Endothelium Leads to Atheroprotective Effect via NF-E2-related Factor 2 (Nrf2) Activation অনুযায়ী Miso Kim, Suji Kim, Jae Hyang Lim, Chu Hee Lee, Hyoung Chul Choi, Chang Hoon Woo
প্রকাশিত 2012Artigo -
4
-
5
-
6
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis... অনুযায়ী Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae‐Lyun Lee
প্রকাশিত 2019Artigo -
7
The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis অনুযায়ী Ryul Kim, Seokyung Hahn, Junghoon Shin, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo
প্রকাশিত 2015Revisão -
8
Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma অনুযায়ী Seong-Ho Kang, Bhumsuk Keam, Yong‐Oon Ahn, Ha-Ram Park, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo
প্রকাশিত 2018Artigo -
9
-
10
Low-dose nivolumab can be effective in non-small cell lung cancer: alternative option for financial toxicity অনুযায়ী Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Se Hyun Kim, Yu Jung Kim, Tae Min Kim, Dong‐Wan Kim, Jong Seok Lee, Dae Seog Heo
প্রকাশিত 2018Artigo -
11
Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines অনুযায়ী Ji‐Eun Park, Seong‐Eun Kim, Bhumsuk Keam, Ha-Ram Park, Soyeon Kim, Miso Kim, Tae Min Kim, Junsang Doh, Dong‐Wan Kim, Dae Seog Heo
প্রকাশিত 2020Artigo -
12
Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration অনুযায়ী Chan-Young Ock, Bhumsuk Keam, Sehui Kim, Ju–Seog Lee, Miso Kim, Tae Min Kim, Yoon Kyung Jeon, Dong‐Wan Kim, Doo Hyun Chung, Dae Seog Heo
প্রকাশিত 2016Artigo -
13
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer অনুযায়ী Soo-Min Kim, Jaemoon Koh, Tae Min Kim, Songji Oh, Soyeon Kim, Jeonghwan Youk, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Dong‐Wan Kim, Dae Seog Heo
প্রকাশিত 2025Artigo -
14
Programmed cell death ligand-1-mediated enhancement of hexokinase 2 expression is inversely related to T-cell effector gene expression in non-small-cell lung cancer অনুযায়ী Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A Kim, Jin Chul Paeng, Chan‐Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung, Yoon Kyung Jeon
প্রকাশিত 2019Artigo -
15
Differences in tumor microenvironments between primary lung tumors and brain metastases in lung cancer patients: therapeutic implications for immune checkpoint inhibitors অনুযায়ী Ryul Kim, Bhumsuk Keam, Sehui Kim, Miso Kim, Se Hyun Kim, Jin‐Wook Kim, Yu Jung Kim, Tae Min Kim, Yoon Kyung Jeon, Dong‐Wan Kim, Doo Hyun Chung, Jong Seok Lee, Dae Seog Heo
প্রকাশিত 2019Artigo -
16
Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after... অনুযায়ী Hong-Sik Kim, Dong‐Wan Kim, Miso Kim, Youngjoo Lee, Hee Kyung Ahn, Jang Ho Cho, Il Hwan Kim, Yun‐Gyoo Lee, Seong Hoon Shin, Song Ee Park, Ji Yoon Jung, Eun Joo Kang, Myung‐Ju Ahn
প্রকাশিত 2021Artigo -
17
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma অনুযায়ী Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Miso Kim, Tae Min Kim, Jin-Ho Kim, Yoon Kyung Jeon, Ju–Seog Lee, Seong Keun Kwon, J. Hun Hah, Tack‐Kyun Kwon, Dong‐Wan Kim, Hong-Gyun Wu, Myung‐Whun Sung, Dae Seog Heo
প্রকাশিত 2016Artigo -
18
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinoma অনুযায়ী Changhee Park, Kwon Joong Na, Hongyoon Choi, Chan‐Young Ock, Seunggyun Ha, Miso Kim, Samina Park, Bhumsuk Keam, Tae Min Kim, Jin Chul Paeng, In Kyu Park, Chang Hyun Kang, Dong‐Wan Kim, Gi Jeong Cheon, Keon Wook Kang, Young Tae Kim, Dae Seog Heo
প্রকাশিত 2020Artigo -
19
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study অনুযায়ী William K. Kelly, Daniel C. Danila, Chia‐Chi Lin, Jae‐Lyun Lee, Nobuaki Matsubara, Patrick J. Ward, Andrew J. Armstrong, David Pook, Miso Kim, Tanya B. Dorff, Stefanie Fischer, Yung‐Chang Lin, Lisa G. Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M. Smith, Jamie N. Connarn, Hweixian Leong Penny, Julia Stieglmaier, Leonard J. Appleman
প্রকাশিত 2023Artigo -
20
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma অনুযায়ী Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E. Hutson, Evgeny Kopyltsov, María José Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung‐Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R. Merchan, Eric Winquist, Pablo Maroto, Jeffrey C. Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frédéric Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E. Dutcus, Alan D. Smith, Lea Dutta, Kalgi Mody, Rodolfo F. Perini, Dongyuan Xing, Toni K. Choueiri
প্রকাশিত 2021Artigo
অনুসন্ধান সাধনীগুলি:
সম্পর্কিত বিষয়
Internal medicine
Medicine
Cancer
Oncology
Immunotherapy
Biology
Cancer research
Lung cancer
Biochemistry
Immune system
Immunology
Chemistry
Nivolumab
Pathology
Pembrolizumab
Adverse effect
Chemotherapy
Clinical trial
Confidence interval
Environmental health
Gene
Genetics
Hazard ratio
Head and neck cancer
Head and neck squamous-cell carcinoma
Phases of clinical research
Population
Renal cell carcinoma
Signal transduction
Sunitinib